Christopher Bloomstran Sanofi Transaction History

Semper Augustus Investments Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$41.48 - $45.59 $5.12 Million - $5.63 Million	-123,472 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$37.63 - $41.22 $729,532 - $799,132	19,387 Added 18.63%	123,472 $4.94 Million
Q1 2018 May 14, 2018	SELL	$38.98 - $45.76 $41,045 - $48,185	-1,053 Reduced 1.0%	104,085 $4.17 Million
Q4 2017 Feb 13, 2018	SELL	$42.86 - $50.61 $2,143 - $2,530	-50 Reduced 0.05%	105,138 $4.52 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $4.95 Million - $5.3 Million	105,188	105,188 $5.24 Million

756

236M

1.27M

1.57M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Semper Augustus Investments Group LLC, based on Form 13F filings with the SEC.

Stay updated on Semper Augustus Investments Group LLC and Christopher Bloomstran with notifications on news.